References
Robak T, Matutes E, Catovsky D, Zinzani PL, Buske C, ESMO Guidelines Committee (2015) Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v100–v107
Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B (2017) Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood 129(5):553–560
Lembersky BC, Ratain MJ, Golomb HM (1988) Skeletal complications in hairy cell leukaemia: diagnosis and therapy. J Clin Oncol 6(8):1280–1284
Filippi AR, Franco P, Marinone C, Tarella C, Ricardi U (2007) Treatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapy. Am J Hematol 82(11):1017–1021
Lal A, Tallman MS, Soble MB, Golubovich I, Peterson L (2002) Hairy cell leukemia presenting as localized skeletal involvement. Leuk Lymphoma 43(11):2207–2211
Karmali R, Farhat M, Leslie W, McIntire MG, Gregory S (2008) Localized bone disease as a presentation of hairy cell leukemia. Clin Adv Hematol Oncol 2008 6(4):290–294
Doma A, Škerget M, Žagar I (2019) 18F-FDG PET/CT for staging and evaluation of therapy in a patient with unusual hairy cell leukemia presentation. Clin Nucl Med 44(7):e458–e460
Gibson G, Lai J, Thomas P (2015) Unusual soft tissue infiltrates with 18F-FDG uptake in a patient with hairy cell leukemia. Clin Nucl Med 40(5):e282–e284
Subhawong AP, Subhawong TK, Ali SZ (2012) Hairy cell leukemia presenting as a peripancreatic mass: cytomorphology and radiographic correlates. Acta Cytol 56(3):463–466
Hammond WA, Swaika A, Menke D, Tun HW (2017) Hairy cell lymphoma: a potentially under-recognized entity. Rare Tumors 9(1):6518
Acknowledgments
We thank Edward Lowczowski from the Medical University of Lodz for editorial assistance. We are grateful to the medical, nursing, and laboratory staff of the participating departments for their contributions to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Statement of informed consent
Informed consent was obtained from the patient included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Robak, P., Jesionek-Kupnicka, D., Kupnicki, P. et al. Multifocal osteolytic lesions in hairy cell leukemia—the importance of PET/CT in diagnosis and assessment. Ann Hematol 100, 1641–1645 (2021). https://doi.org/10.1007/s00277-020-04121-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-04121-3